Literature DB >> 27439352

Managing non-alcoholic fatty liver disease.

Jing Hieng Ngu1,2, George Boon Bee Goh1,2, Zhongxian Poh3, Roy Soetikno1,2.   

Abstract

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly with the obesity and diabetes mellitus epidemics. It is rapidly becoming the most common cause of liver disease worldwide. NAFLD can progress to serious complications such as cirrhosis, hepatocellular carcinoma and death. Therefore, it is important to recognise this condition so that early intervention can be implemented. Lifestyle modifications and strict control of metabolic risk factors are the mainstay of treatment. As disease progression is slow in the majority of NAFLD patients, most can be managed well by primary care physicians. NAFLD patients with advanced liver fibrosis should be referred to specialist care for further assessment. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  fibrosis; metabolic syndrome; non-alcoholic fatty liver disease

Mesh:

Year:  2016        PMID: 27439352      PMCID: PMC4958712          DOI: 10.11622/smedj.2016119

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  22 in total

Review 1.  From NAFLD in clinical practice to answers from guidelines.

Authors:  Fabio Nascimbeni; Raluca Pais; Stefano Bellentani; Christopher Paul Day; Vlad Ratziu; Paola Loria; Amedeo Lonardo
Journal:  J Hepatol       Date:  2013-06-07       Impact factor: 25.083

Review 2.  Should we lower lipids in nonalcoholic fatty liver disease?

Authors:  Geoffrey Farrell
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-16       Impact factor: 11.382

Review 3.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

Authors:  Siddharth Singh; Alina M Allen; Zhen Wang; Larry J Prokop; Mohammad H Murad; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

4.  Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study.

Authors:  George Boon-Bee Goh; Wan-Cheng Chow; Renwei Wang; Jian-Min Yuan; Woon-Puay Koh
Journal:  Hepatology       Date:  2014-06-24       Impact factor: 17.425

5.  Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.

Authors:  Mika Yamamoto; Motoh Iwasa; Kazuko Iwata; Masahiko Kaito; Ryosuke Sugimoto; Naohito Urawa; Rumi Mifuji; Masayoshi Konishi; Yoshinao Kobayashi; Yukihiko Adachi
Journal:  J Gastroenterol Hepatol       Date:  2007-04       Impact factor: 4.029

6.  Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease.

Authors:  Claudia O Zein; Aynur Unalp; Ryan Colvin; Yao-Chang Liu; Arthur J McCullough
Journal:  J Hepatol       Date:  2010-09-22       Impact factor: 25.083

7.  Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease.

Authors:  George B Goh; Mangesh R Pagadala; Jaividhya Dasarathy; Aynur Unalp-Arida; Ruth Sargent; Carol Hawkins; Achuthan Sourianarayanane; Amer Khiyami; Lisa Yerian; Rish Pai; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Liver Int       Date:  2014-07-05       Impact factor: 5.828

Review 8.  Prevalence of Nonalcoholic Fatty Liver Disease and Economy.

Authors:  Jin-Zhou Zhu; Yi-Ning Dai; Yu-Ming Wang; Qin-Yi Zhou; Chao-Hui Yu; You-Ming Li
Journal:  Dig Dis Sci       Date:  2015-05-28       Impact factor: 3.199

9.  The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors:  Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

10.  Perceptions of non-alcoholic fatty liver disease - an Asian community-based study.

Authors:  George B B Goh; Clarence Kwan; Sze Ying Lim; Nanda Kk Venkatanarasimha; Rafidah Abu-Bakar; Thinesh L Krishnamoorthy; Hang Hock Shim; Kiang Hiong Tay; Wan Cheng Chow
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-10-12
View more
  2 in total

1.  Public awareness and knowledge of liver health and diseases in Singapore.

Authors:  Chee-Kiat Tan; George Boon-Bee Goh; Jin Youn; Jacques Chak-Kwan Yu; Shikha Singh
Journal:  J Gastroenterol Hepatol       Date:  2021-03-30       Impact factor: 4.369

2.  Establishing a genetic link between FTO and VDR gene polymorphisms and obesity in the Emirati population.

Authors:  Saad Mahmud Khan; Sarah El Hajj Chehadeh; Mehera Abdulrahman; Wael Osman; Habiba Al Safar
Journal:  BMC Med Genet       Date:  2018-01-17       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.